Vertex Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VRTX and other ETFs, options, and stocks.About VRTX
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis.
VRTX Key Statistics
VRTX News
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Maximize Your Po...
Vertex Pharmaceuticals (VRTX) stock has performed strongly since the turn of the year, gaining 14.6% and vastly outperforming the healthcare sector as a whole....
Vertex Pharmaceuticals (VRTX 5.31%) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 days. On Dec. 20, 2024, the FDA gave a t...
Analyst ratings
61%
of 36 ratingsMore VRTX News
Vertex Pharmaceuticals is the first drugmaker in decades to have a non-opioid approved to treat moderate to severe acute pain. The FDA said the approval of Jour...
Vertex Pharmaceuticals Inc. VRTX shares are trading higher Friday following two major developments that strengthen its position in both pain management and gene...
Vertex Pharmaceuticals (VRTX-0.70% ) stock rose on Friday after the Food and Drug Administration (FDA) approved its new painkiller, the first of its kind approv...
Baird lowered the firm’s price target on Vertex Pharmaceuticals (VRTX) to $320 from $325 and keeps an Underperform rating on the shares. The firm noted the appr...
Vertex Pharmaceuticals (NASDAQ:VRTX) announced Friday a reimbursement agreement with England’s National Health Service (NHS) to allow patients with sickle cell...
U.S.-based Vertex Pharmaceuticals (VRTX) has secured approval from the FDA (Food and Drug Administration) for its long-awaited non-opioid painkiller. The approv...
Vertex Pharmaceuticals (VRTX) rose Thursday night after the FDA approved its non-opioid painkiller Journavx. The first-in-class drug, also known as suzetrigine...
